Framingham congestive-heart-failure score: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: The '''Framingham congestive-heart-failure score''' can be used to diagnose heart failure and monitor its response to treatment.<ref name="pmid8376698">{{cite journal| author=Ho KK,...) |
Pat Palmer (talk | contribs) (resolved duplicate ref) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
The '''Framingham congestive-heart-failure score''' can be used to diagnose [[heart failure]] and monitor its response to treatment.<ref name="pmid8376698">{{cite journal| author=Ho KK, Pinsky JL, Kannel WB, Levy D| title=The epidemiology of heart failure: the Framingham Study. | journal=J Am Coll Cardiol | year= 1993 | volume= 22 | issue= 4 Suppl A | pages= 6A-13A | pmid=8376698 | The '''Framingham congestive-heart-failure score''' can be used to diagnose [[heart failure]] and monitor its response to treatment.<ref name="pmid8376698">{{cite journal| author=Ho KK, Pinsky JL, Kannel WB, Levy D| title=The epidemiology of heart failure: the Framingham Study. | journal=J Am Coll Cardiol | year= 1993 | volume= 22 | issue= 4 Suppl A | pages= 6A-13A | pmid=8376698 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=8376698 }} </ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=8376698 }} </ref> | ||
| Line 16: | Line 17: | ||
==Clinical uses of the score== | ==Clinical uses of the score== | ||
The score can be used (two major or one major and two minor criteria) to diagnose [[heart failure]].<ref name="pmid8376698" | The score can be used (two major or one major and two minor criteria) to diagnose [[heart failure]].<ref name="pmid8376698"/> | ||
The score can also be used to monitor the response to treatment for heart failure. Targeting a clinical score to a score of 2 or less may<ref name="pmid20117364">{{cite journal| author=Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG et al.| title=N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. | journal=J Am Coll Cardiol | year= 2009 | volume= 55 | issue= 1 | pages= 53-60 | pmid=20117364 | The score can also be used to monitor the response to treatment for heart failure. Targeting a clinical score to a score of 2 or less may<ref name="pmid20117364">{{cite journal| author=Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG et al.| title=N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. | journal=J Am Coll Cardiol | year= 2009 | volume= 55 | issue= 1 | pages= 53-60 | pmid=20117364 | ||
Latest revision as of 12:50, 17 August 2024
The Framingham congestive-heart-failure score can be used to diagnose heart failure and monitor its response to treatment.[1]
Calculation of the score
- Major findings (1 point each)
- Paroxysmal nocturnal dyspnea
- Abdominojugular test positive
- Third heart sound present
- Basal crackles
- Minor findings (0.5 point each)
- Orthopnea
- Reduction in exercise tolerance
- Resting heart rate > 100 bpm
- Hepatomegaly
- Peripheral edema
Clinical uses of the score
The score can be used (two major or one major and two minor criteria) to diagnose heart failure.[1]
The score can also be used to monitor the response to treatment for heart failure. Targeting a clinical score to a score of 2 or less may[2] or may[3] not be similar to targeting brain natriuretic peptide (BNP) level.
References
- ↑ 1.0 1.1 Ho KK, Pinsky JL, Kannel WB, Levy D (1993). "The epidemiology of heart failure: the Framingham Study.". J Am Coll Cardiol 22 (4 Suppl A): 6A-13A. PMID 8376698.
- ↑ Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG et al. (2009). "N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.". J Am Coll Cardiol 55 (1): 53-60. DOI:10.1016/j.jacc.2009.02.095. PMID 20117364. Research Blogging.
- ↑ Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000). "Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.". Lancet 355 (9210): 1126-30. PMID 10791374.